SEC Form 4 · accession 0001179110-16-024853
Allergan plc · AGN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
William Meury
Officer — Chief Communication Officer
Period of report
May 15, 2016
Accepted (ET)
May 17, 2016 · 4:23 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001578845
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares, par value $0.0001 | May 15, 2016 | F | 713 | $223.35 | D | 37,569 | D | |
| Ordinary Shares, par value $0.0001F1 | May 15, 2016 | F | 510 | $223.35 | D | 37,059 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Includes restricted shares issued pursuant to the 2013 Incentive Award Plan of Allergan plc.